These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 24029118)

  • 1. Chronic neutrophilic leukaemia.
    Bain BJ
    Acta Haematol; 2014; 131(1):45. PubMed ID: 24029118
    [No Abstract]   [Full Text] [Related]  

  • 2. Presence of the JAK2 V617F mutation in a patient with chronic neutrophilic leukemia and effective response to interferon α-2b.
    Zhang X; Pan J; Guo J
    Acta Haematol; 2013; 130(1):44-6. PubMed ID: 23391844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of JAK2 V617F tyrosine kinase mutation as a myeloid-lineage-specific mutation in chronic neutrophilic leukaemia.
    Lea NC; Lim Z; Westwood NB; Arno MJ; Gäken J; Mohamedali A; Mufti GJ
    Leukemia; 2006 Jul; 20(7):1324-6. PubMed ID: 16673022
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic neutrophilic leukemia with an associated V617F JAK2 tyrosine kinase mutation.
    Mc Lornan DP; Percy MJ; Jones AV; Cross NC; Mc Mullin MF
    Haematologica; 2005 Dec; 90(12):1696-7. PubMed ID: 16330446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic neutrophilia associated with myeloma: is it clonal?
    Nedeljkovic M; He S; Szer J; Juneja S
    Leuk Lymphoma; 2014 Feb; 55(2):439-40. PubMed ID: 23713456
    [No Abstract]   [Full Text] [Related]  

  • 6. Early relapse of JAK2 V617F-positive chronic neutrophilic leukemia with central nervous system infiltration after unrelated bone marrow transplantation.
    Kako S; Kanda Y; Sato T; Goyama S; Noda N; Shoda E; Oshima K; Inoue M; Izutsu K; Watanabe T; Motokura T; Chiba S; Fukayama M; Kurokawa M
    Am J Hematol; 2007 May; 82(5):386-90. PubMed ID: 17109389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic neutrophilic leukaemia.
    Gan GG; Pasagna JF; Eow GI; Nadarajan VS
    Singapore Med J; 2007 Mar; 48(3):e74-6. PubMed ID: 17342275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful alpha-2b-interferon therapy for chronic neutrophilic leukemia.
    Meyer S; Feremans W; Cantiniaux B; Capel P; Huygen K; Dicato M
    Am J Hematol; 1993 Aug; 43(4):307-9. PubMed ID: 8372813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon alpha induces a good molecular response in a patient with chronic eosinophilic leukemia (CEL) carrying the JAK2V617F point mutation.
    Helbig G; Stella-Holowiecka B; Majewski M; Lewandowska M; Holowiecki J
    Haematologica; 2007 Nov; 92(11):e118-9. PubMed ID: 18024388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights on mechanisms of clonal evolution in chronic neutrophilic leukemia on ruxolitinib therapy.
    Stoner RC; Press RD; Maxson JE; Tyner JW; Dao KT
    Leukemia; 2020 Jun; 34(6):1684-1688. PubMed ID: 31844143
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical response to ruxolitinib in CSF3R T618-mutated chronic neutrophilic leukemia.
    Stahl M; Xu ML; Steensma DP; Rampal R; Much M; Zeidan AM
    Ann Hematol; 2016 Jun; 95(7):1197-200. PubMed ID: 27068405
    [No Abstract]   [Full Text] [Related]  

  • 12. Chronic neutrophilic leukemia, a rare case of leukocytosis.
    Wang X; Resendes NM; Shanahan L; Hutchinson L; Woda B; Cerny J
    Leuk Res; 2020 Jul; 94():106384. PubMed ID: 32447046
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes in allele frequencies of
    Nooruddin Z; Miltgen N; Wei Q; Schowinsky J; Pan Z; Tobin J; Purev E; Gutman JA; Robinson W; Pollyea DA
    Haematologica; 2017 May; 102(5):e207-e209. PubMed ID: 28209656
    [No Abstract]   [Full Text] [Related]  

  • 14. Durable remission with ruxolitinib in a chronic neutrophilic leukemia patient harboring a truncation and membrane proximal CSF3R compound mutation.
    Hinze A; Rinke J; Hochhaus A; Ernst T
    Ann Hematol; 2021 Feb; 100(2):581-584. PubMed ID: 32577845
    [No Abstract]   [Full Text] [Related]  

  • 15. A case of plasma cell neoplasm-associated chronic neutrophilic leukemia with ASXL1 and JAK2V617F mutations.
    Lauw MIS; Hakim N; Arora S; Prakash S; Xie Y
    Ann Hematol; 2022 Aug; 101(8):1879-1881. PubMed ID: 35419626
    [No Abstract]   [Full Text] [Related]  

  • 16. Next-generation sequencing panel for diagnosis and management of chronic neutrophilic leukaemia: a case report.
    Mak KY; Au CH; Chan TL; Ma ESK; Chow EYD; Lin SY; Choi WWL
    Hong Kong Med J; 2019 Jun; 25(3):248-250. PubMed ID: 31182673
    [No Abstract]   [Full Text] [Related]  

  • 17. Familial occurrence of chronic neutrophilic leukaemia.
    Kojima K; Yasukawa M; Hara M; Nawa Y; Kimura Y; Narumi H; Fujita S
    Br J Haematol; 1999 May; 105(2):428-30. PubMed ID: 10233414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained major molecular response on interferon alpha-2b in two patients with polycythemia vera.
    Larsen TS; Bjerrum OW; Pallisgaard N; Andersen MT; Møller MB; Hasselbalch HC
    Ann Hematol; 2008 Oct; 87(10):847-50. PubMed ID: 18481066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New mutations in myeloproliferative neoplasms; 2014 update].
    Kirito K
    Rinsho Ketsueki; 2014 Oct; 55(10):1833-40. PubMed ID: 25297747
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic neutrophilic leukaemia associated with polycythemia vera: pathogenetic implications and therapeutic approach.
    Foa P; Iurlo A; Saglio G; Guerrasio A; Capsoni F; Maiolo AT
    Br J Haematol; 1991 Jun; 78(2):286-8. PubMed ID: 2064971
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.